Ovarian Cancer

Wip1 could be new target for cancer treatment

Researchers have uncovered mutations in the phosphatase Wip1 that enable cancer cells to foil the tumor suppressor p53, according to a study in The Journal of Cell Biology. The results could provide a new ...

May 06, 2013
popularity not rated yet | comments 0

New genetic clues to breast and ovarian cancer

(Medical Xpress)—A major international study involving a Simon Fraser University scientist has found that sequence differences in a gene crucial to the maintenance of our chromosomes' integrity predispose us to certain ...

May 01, 2013
popularity not rated yet | comments 0 | with audio podcast

Chemoresponse assay helps boost ovarian cancer survival

This spring, a team of researchers has released results from an eight-year study that shows improved survival rates for women diagnosed with ovarian cancer who undergo cancer tumor testing to determine the best treatment.

Apr 25, 2013
popularity 5 / 5 (1) | comments 0

Screening detects ovarian cancer using neighboring cells

Pioneering biophotonics technology developed at Northwestern University is the first screening method to detect the early presence of ovarian cancer in humans by examining cells easily brushed from the neighboring cervix ...

Apr 22, 2013
popularity 5 / 5 (1) | comments 0 | with audio podcast

Court: Can human genes be patented? (Update)

The Supreme Court grapples Monday with the question of whether human genes can be patented, and the ultimate answer could reshape U.S. medical research, the fight against diseases like breast and ovarian ...

Apr 15, 2013
popularity 5 / 5 (1) | comments 1

US top court to hear case on gene patents

The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.

Apr 13, 2013
popularity 5 / 5 (2) | comments 0

Targeted toxin active in platinum-resistant ovarian cancers

A new antibody-guided drug has shown promising activity in a phase I trial involving ovarian cancer patients with platinum drug-resistant disease, researchers from Dana-Farber Cancer Institute will report today at the annual ...

Apr 06, 2013
popularity not rated yet | comments 0

Latest Spotlight News

Hepatitis C virus genotype 1 is most prevalent worldwide

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journa ...

New tools help neuroscientists analyze 'big data'

In an age of "big data," a single computer cannot always find the solution a user wants. Computational tasks must instead be distributed across a cluster of computers that analyze a massive data set together. ...